D. E. Shaw & Co., Inc. - SAGENT PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
D. E. Shaw & Co., Inc. ownership history of SAGENT PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2016$590,000
-41.6%
39,368
-52.6%
0.00%
-50.0%
Q1 2016$1,011,000
+103.8%
83,071
+166.6%
0.00%
+100.0%
Q4 2015$496,000
+67.0%
31,154
+166.0%
0.00%
Q4 2013$297,000
-84.8%
11,713
-87.8%
0.00%
-100.0%
Q3 2013$1,952,00095,6690.00%
Other shareholders
SAGENT PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
SENZAR ASSET MANAGEMENT, LLC 453,392$11,022,0001.89%
GREAT POINT PARTNERS LLC 141,900$3,450,0001.34%
Penn Capital Management Company, LLC 1,247,428$30,325,0001.25%
Ranger Investment Management 982,240$23,878,0001.16%
HealthCor Management, L.P. 912,381$22,180,0001.12%
Piermont Capital Management Inc. 138,380$3,364,0001.02%
JW Asset Management, LLC 111,630$2,714,0000.82%
SECTORAL ASSET MANAGEMENT INC 465,625$11,319,0000.47%
ACUTA CAPITAL PARTNERS, LLC 28,000$681,0000.42%
Tekla Capital Management LLC 409,500$9,955,0000.36%
View complete list of SAGENT PHARMACEUTICALS INC shareholders